BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 38433231)

  • 1. Change in chemotherapy during concurrent radiation followed by surgery after a suboptimal positron emission tomography response to induction chemotherapy improves outcomes for locally advanced esophageal adenocarcinoma.
    Ku GY; Kriplani A; Janjigian YY; Kelsen DP; Rusch VW; Bains M; Chou J; Capanu M; Wu AJ; Goodman KA; Ilson DH
    Cancer; 2016 Jul; 122(13):2083-90. PubMed ID: 27152857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Top advances of the year: Gastroesophageal cancer.
    Goodman KA; Hotca A; Liu M; Strong VE; Ilson DH
    Cancer; 2024 Jul; 130(13):2253-2256. PubMed ID: 38578983
    [No Abstract]   [Full Text] [Related]  

  • 3. ASO Author Reflections: Neoadjuvant Chemotherapy versus Definitive Chemoradiation Therapy for Locally Advanced Cervical Esophageal Cancer: A Retrospective Study.
    Kubo Y; Kato K; Daiko H
    Ann Surg Oncol; 2024 May; ():. PubMed ID: 38802715
    [No Abstract]   [Full Text] [Related]  

  • 4. Author Correction: Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trial.
    Verschoor YL; van de Haar J; van den Berg JG; van Sandick JW; Kodach LL; van Dieren JM; Balduzzi S; Grootscholten C; IJsselsteijn ME; Veenhof AAFA; Hartemink KJ; Vollebergh MA; Jurdi A; Sharma S; Spickard E; Owers EC; Bartels-Rutten A; den Hartog P; de Miranda NFCC; van Leerdam ME; Haanen JBAG; Schumacher TN; Voest EE; Chalabi M
    Nat Med; 2024 May; 30(5):1499. PubMed ID: 38448792
    [No Abstract]   [Full Text] [Related]  

  • 5. Gastroesophageal junction adenocarcinoma.
    Swisher SG; Pisters PW; Komaki R; Lahoti S; Ajani JA
    Curr Treat Options Oncol; 2000 Dec; 1(5):387-98. PubMed ID: 12057146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter analysis on the value of standard (chemo)radiotherapy in elderly patients with locally advanced adenocarcinoma of the esophagus or gastroesophageal junction.
    Bostel T; Nikolaidou E; Wollschläger D; Mayer A; Kaufmann J; Hopprich A; Rühle A; Grosu AL; Debus J; Fottner C; Moehler M; Grimminger P; Schmidberger H; Nicolay NH
    Radiat Oncol; 2024 Mar; 19(1):28. PubMed ID: 38433231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perioperative chemo(radio)therapy versus primary surgery for resectable adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagus.
    Ronellenfitsch U; Schwarzbach M; Hofheinz R; Kienle P; Kieser M; Slanger TE; Jensen K;
    Cochrane Database Syst Rev; 2013 May; (5):CD008107. PubMed ID: 23728671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perioperative chemotherapy vs. neoadjuvant chemoradiation in gastroesophageal junction adenocarcinoma : A population-based evaluation of the Munich Cancer Registry.
    Münch S; Habermehl D; Agha A; Belka C; Combs SE; Eckel R; Friess H; Gerbes A; Nüssler NC; Schepp W; Schmid RM; Schmitt W; Schubert-Fritschle G; Weber B; Werner J; Engel J
    Strahlenther Onkol; 2018 Feb; 194(2):125-135. PubMed ID: 29071366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis after neoadjuvant chemoradiation or chemotherapy for locally advanced gastro-oesophageal junctional adenocarcinoma.
    Vos EL; Carr RA; Hsu M; Nakauchi M; Nobel T; Russo A; Barbetta A; Tan KS; Tang L; Ilson D; Ku GY; Wu AJ; Janjigian YY; Yoon SS; Bains MS; Jones DR; Coit D; Molena D; Strong VE
    Br J Surg; 2021 Nov; 108(11):1332-1340. PubMed ID: 34476473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of comprehensive geriatric assessment on care received, treatment completion, toxicity, cancer-related and geriatric assessment outcomes, and quality of life for older adults receiving systemic anti-cancer treatment: A systematic review.
    Disalvo D; Moth E; Soo WK; Garcia MV; Blinman P; Steer C; Amgarth-Duff I; Power J; Phillips J; Agar M
    J Geriatr Oncol; 2023 Nov; 14(8):101585. PubMed ID: 37573197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemoradiotherapy in geriatric patients with squamous cell carcinoma of the esophagus: Multi-center analysis on the value of standard treatment in the elderly.
    Bostel T; Akbaba S; Wollschläger D; Mayer A; Nikolaidou E; Murnik M; Kirste S; Rühle A; Grosu AL; Debus J; Fottner C; Moehler M; Grimminger P; Schmidberger H; Nicolay NH
    Front Oncol; 2023; 13():1063670. PubMed ID: 36937445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trimodality Therapy vs Definitive Chemoradiation in Older Adults With Locally Advanced Esophageal Cancer.
    Gaber CE; Shaheen NJ; Edwards JK; Sandler RS; Nichols HB; Sanoff HK; Lund JL
    JNCI Cancer Spectr; 2022 Nov; 6(6):. PubMed ID: 36205723
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.